Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ASML Holding stock logo
ASML
ASML
$924.97
+0.6%
$940.72
$563.99
$1,056.34
$364.98B1.491.17 million shs703,519 shs
DocuSign, Inc. stock logo
DOCU
DocuSign
$60.22
+0.5%
$58.34
$38.11
$64.76
$12.37B0.882.95 million shs675,478 shs
GitLab Inc. stock logo
GTLB
GitLab
$56.26
-0.4%
$55.74
$31.56
$78.53
$8.92B0.492.44 million shs1.52 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$154.68
+0.3%
$152.40
$143.13
$175.97
$372.27B0.557.37 million shs6.51 million shs
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$19.71
+0.6%
$18.39
$15.89
$19.79
$43.74B0.8913.97 million shs12.15 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$131.89
-0.9%
$128.09
$75.56
$138.28
$591.86B0.434.73 million shs2.59 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$177.46
+1.5%
$170.77
$138.80
$299.29
$565.96B2.41101.58 million shs76.62 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$524.65
+0.6%
$485.45
$436.38
$554.70
$482.88B0.554.25 million shs2.66 million shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ASML Holding stock logo
ASML
ASML
-1.91%+0.66%-5.87%-1.01%+37.14%
DocuSign, Inc. stock logo
DOCU
DocuSign
-2.01%+4.57%+3.74%+19.28%+14.55%
GitLab Inc. stock logo
GTLB
GitLab
-1.05%+6.79%+4.90%-22.99%+77.62%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.03%+2.95%+6.80%-1.46%-2.97%
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
+0.33%+3.08%+10.83%+14.55%+19.15%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-1.19%+3.43%+7.77%+7.29%+218.47%
Tesla, Inc. stock logo
TSLA
Tesla
+0.49%+1.67%+11.29%-12.56%+0.56%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+0.76%+2.83%+11.14%+0.01%+7.55%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ASML Holding stock logo
ASML
ASML
4.2074 of 5 stars
3.45.01.70.02.60.03.1
DocuSign, Inc. stock logo
DOCU
DocuSign
3.4609 of 5 stars
1.05.00.03.52.02.51.9
GitLab Inc. stock logo
GTLB
GitLab
3.9109 of 5 stars
4.43.00.00.02.74.20.6
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8796 of 5 stars
3.23.04.23.93.11.71.9
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
3.1451 of 5 stars
1.13.02.50.82.83.31.3
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
1.6966 of 5 stars
1.43.01.70.02.00.03.1
Tesla, Inc. stock logo
TSLA
Tesla
4.4046 of 5 stars
2.03.00.03.52.94.22.5
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.9014 of 5 stars
2.45.04.24.01.82.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ASML Holding stock logo
ASML
ASML
2.85
Moderate Buy$1,036.0012.00% Upside
DocuSign, Inc. stock logo
DOCU
DocuSign
2.00
Hold$60.250.06% Upside
GitLab Inc. stock logo
GTLB
GitLab
2.87
Moderate Buy$70.5025.31% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8613.69% Upside
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
2.29
Hold$20.202.49% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.75
Moderate Buy$133.601.30% Upside
Tesla, Inc. stock logo
TSLA
Tesla
2.06
Hold$185.904.75% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.83
Moderate Buy$570.058.65% Upside

Current Analyst Ratings

Latest NVO, UNH, JNJ, GTLB, DOCU, TSLA, KMI, and ASML Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2024
GitLab Inc. stock logo
GTLB
GitLab
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $70.00
5/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00
5/6/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
5/2/2024
Tesla, Inc. stock logo
TSLA
Tesla
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$230.00
4/29/2024
Tesla, Inc. stock logo
TSLA
Tesla
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$155.00 ➝ $145.00
4/29/2024
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$275.00
4/25/2024
Tesla, Inc. stock logo
TSLA
Tesla
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$123.00 ➝ $136.00
4/24/2024
Tesla, Inc. stock logo
TSLA
Tesla
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$180.00 ➝ $182.00
4/24/2024
Tesla, Inc. stock logo
TSLA
Tesla
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetReduce ➝ Reduce$138.00 ➝ $120.00
4/24/2024
Tesla, Inc. stock logo
TSLA
Tesla
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$160.00 ➝ $147.00
4/24/2024
Tesla, Inc. stock logo
TSLA
Tesla
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$294.00 ➝ $293.00
(Data available from 5/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ASML Holding stock logo
ASML
ASML
$29.82B12.24$23.22 per share39.84$37.95 per share24.37
DocuSign, Inc. stock logo
DOCU
DocuSign
$2.76B4.48$2.12 per share28.36$5.54 per share10.87
GitLab Inc. stock logo
GTLB
GitLab
$579.91M15.39N/AN/A$3.92 per share14.35
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.37$13.85 per share11.17$29.09 per share5.32
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$15.33B2.85$2.14 per share9.19$14.30 per share1.38
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$33.71B17.56$2.95 per share44.72$3.21 per share41.09
Tesla, Inc. stock logo
TSLA
Tesla
$96.77B5.85$4.40 per share40.33$20.42 per share8.69
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$371.62B1.30$30.19 per share17.38$100.36 per share5.23

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ASML Holding stock logo
ASML
ASML
$8.48B$19.5847.2430.312.3427.23%56.99%18.51%7/17/2024 (Estimated)
DocuSign, Inc. stock logo
DOCU
DocuSign
$73.98M$0.36167.2749.365.282.68%13.91%4.04%6/6/2024 (Confirmed)
GitLab Inc. stock logo
GTLB
GitLab
-$424.17M-$2.75N/AN/AN/A-73.14%-18.26%-10.65%6/3/2024 (Confirmed)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.6414.162.5245.26%36.70%15.07%7/18/2024 (Estimated)
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$2.39B$1.1017.9216.165.4516.08%7.85%3.57%7/17/2024 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$12.15B$2.9045.4830.821.9136.56%91.70%29.86%8/8/2024 (Estimated)
Tesla, Inc. stock logo
TSLA
Tesla
$15.00B$3.9245.2772.144.8014.37%13.18%7.72%7/17/2024 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$22.38B$16.3632.0716.941.504.05%26.50%8.60%7/12/2024 (Estimated)

Latest NVO, UNH, JNJ, GTLB, DOCU, TSLA, KMI, and ASML Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/6/2024N/A
DocuSign, Inc. stock logo
DOCU
DocuSign
$0.7860N/A-$0.7860N/AN/AN/A  
6/3/2024N/A
GitLab Inc. stock logo
GTLB
GitLab
-$0.0360N/A+$0.0360N/AN/AN/A  
4/23/2024Q1 2024
Tesla, Inc. stock logo
TSLA
Tesla
$0.35$0.35N/A$0.36$22.15 billion$21.30 billion
4/17/2024Q1 2024
ASML Holding stock logo
ASML
ASML
$2.84$3.38+$0.54$3.38$5.73 billion$5.74 billion
4/17/2024Q1 24
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$0.34$0.34N/A$0.35$4.36 billion$3.84 billion      
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
4/16/2024Q1 24
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.63$6.91+$0.28$15.35$99.23 billion$99.80 billion    
3/7/2024Q4 2024
DocuSign, Inc. stock logo
DOCU
DocuSign
$0.09$0.15+$0.06$0.17$698.05 million$712.39 million
3/4/202401/31/2024
GitLab Inc. stock logo
GTLB
GitLab
$0.0830$0.15+$0.0670-$0.01$157.89 million$163.80 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ASML Holding stock logo
ASML
ASML
$6.370.69%+31.28%32.53%1 Years
DocuSign, Inc. stock logo
DOCU
DocuSign
N/AN/AN/AN/AN/A
GitLab Inc. stock logo
GTLB
GitLab
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.08%+5.70%29.68%63 Years
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
$1.155.83%+2.74%104.55%7 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.331.01%+16.52%45.86%1 Years
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$7.521.43%+14.71%45.97%14 Years

Latest NVO, UNH, JNJ, GTLB, DOCU, TSLA, KMI, and ASML Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
4/17/2024
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
quarterly$0.28756.2%4/29/20244/30/20245/15/2024
4/26/2024
ASML Holding stock logo
ASML
ASML
Quarterly$1.34300.62%4/26/20244/29/20245/7/2024
2/23/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$1.881.43%3/8/20243/11/20243/19/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ASML Holding stock logo
ASML
ASML
0.33
1.54
0.88
DocuSign, Inc. stock logo
DOCU
DocuSign
N/A
0.94
0.94
GitLab Inc. stock logo
GTLB
GitLab
N/A
1.93
1.93
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.94
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
0.95
0.50
0.38
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.17
0.70
0.50
Tesla, Inc. stock logo
TSLA
Tesla
0.04
1.72
1.17
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.69
0.85
0.85

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ASML Holding stock logo
ASML
ASML
26.07%
DocuSign, Inc. stock logo
DOCU
DocuSign
77.64%
GitLab Inc. stock logo
GTLB
GitLab
91.72%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
62.52%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
Tesla, Inc. stock logo
TSLA
Tesla
66.20%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
ASML Holding stock logo
ASML
ASML
N/A
DocuSign, Inc. stock logo
DOCU
DocuSign
1.66%
GitLab Inc. stock logo
GTLB
GitLab
21.36%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
12.64%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
Tesla, Inc. stock logo
TSLA
Tesla
25.10%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.33%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ASML Holding stock logo
ASML
ASML
42,416394.59 millionN/AOptionable
DocuSign, Inc. stock logo
DOCU
DocuSign
6,840205.41 million202.01 millionOptionable
GitLab Inc. stock logo
GTLB
GitLab
2,130158.60 million124.72 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
10,8912.22 billion1.94 billionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
63,3704.49 billion4.48 billionOptionable
Tesla, Inc. stock logo
TSLA
Tesla
140,4733.19 billion2.39 billionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
440,000920.39 million917.35 millionOptionable

NVO, UNH, JNJ, GTLB, DOCU, TSLA, KMI, and ASML Headlines

Recent News About These Companies

UnitedHealth Group (NYSE:UNH) Trading Up 0.2%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ASML logo

ASML

NASDAQ:ASML
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems for chipmakers. It offers advanced semiconductor equipment systems, including lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical metrology systems to assess the quality of patterns on the wafers; and HMI electron beam solutions to locate and analyze individual chip defects. Further, the company provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
DocuSign logo

DocuSign

NASDAQ:DOCU
DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account; Notary which enables notaries public to conduct remote online notarization transactions; and Web Forms, a web forms that quickly draft agreements using pre-populated data from completed forms or external systems via APIs. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally. Signature and CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and digital self-service purchasing. DocuSign, Inc. was incorporated in 2003 and is headquartered in San Francisco, California.
GitLab logo

GitLab

NASDAQ:GTLB
GitLab Inc., through its subsidiaries, develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific. It offers GitLab, a DevOps platform, which is a single application that leads to faster cycle time and allows visibility throughout and control over various stages of the DevOps lifecycle. The company helps organizations to plan, build, secure, and deploy software to drive business outcomes. It also provides related training and professional services. The company was formerly known as GitLab B.V. and changed its name to GitLab Inc. in July 2015. GitLab Inc. was founded in 2011 and is headquartered in San Francisco, California.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Kinder Morgan logo

Kinder Morgan

NYSE:KMI
Kinder Morgan, Inc. operates as an energy infrastructure company primarily in North America. The company operates through Natural Gas Pipelines, Products Pipelines, Terminals, and CO2 segments. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas gasification, liquefaction, and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, renewable fuel and feedstocks, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 82,000 miles of pipelines and 139 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was incorporated in 2006 and is headquartered in Houston, Texas.
Novo Nordisk A/S logo

Novo Nordisk A/S

NYSE:NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Tesla logo

Tesla

NASDAQ:TSLA
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.
UnitedHealth Group logo

UnitedHealth Group

NYSE:UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.